Clinical Trials Sponsored by Verily Life Sciences LLC

Total 76 results

Verily Life Sciences LLC

Completed

Baseline Sleep Apnea Study #2

Obstructive Sleep Apnea of Adult

United States
Verily Life Sciences LLC

Completed

Predictors of Severe COVID-19 Outcomes (PRESCO)

COVID-19 | Acute Respiratory Distress Syndrome

United States
Verily Life Sciences LLC

Withdrawn

Verily Watch Cardio (AF and ECG) Study

Atrial Fibrillation

United States
Verily Life Sciences LLC

Not yet recruiting

Verily Clinical Study Watch Analytical Validation Study

Healthy Population

United States
Verily Life Sciences LLC

Completed

Study Watch Sleep Metric Performance Characterization Study

Insomnia | Sleep | Obstructive Sleep Apnea

United States
Verily Life Sciences LLC

Completed

Gastroenterology Artificial INtelligence System for Detecting Colorectal Polyps (The GAIN Study) (GAIN)

Colon Adenoma | Colon Polyp | Colon Lesion

United States, Israel
Verily Life Sciences LLC

Completed

Study Watch AF Detection At Home

Atrial Fibrillation

United States
Verily Life Sciences LLC

Completed

Onduo Virtual Diabetes Clinic Study (VDC)

Diabetes Mellitus, Type 2

United States
Verily Life Sciences LLC

Terminated

A Clinical Data Collection Study of Verily Patch

Febrile | Afebrile

United States
Verily Life Sciences LLC

Completed

Study Watch Atrial Fibrillation (AF) Detection Investigation

Atrial Fibrillation

United States
L'Oreal
Verily Life Sciences

Recruiting

My Skin & Hair Journey_virtual Registry

Skin | Hair

United States
Radboud University Medical Center
Verily Life Sciences LLC

Completed

The ADAPT-study: Measuring Physical Performance Using Wearable Sensors in Parkinson's Disease and COPD (ADAPT) (ADAPT)

Parkinson Disease | COPD

Netherlands
Verily Life Sciences LLC
The Emmes Company, LLC; Optos, PLC; Google LLC.; Nikon Corporation

Completed

ARDA Software for the Detection of mtmDR

Diabetic Retinopathy

United States
Radboud University Medical Center
UCB Pharma; Verily Life Sciences LLC

Recruiting

Personalized Parkinson Project PSP Cohort (PPP-PSP)

Brain Diseases | Movement Disorders | Neurodegenerative Diseases | Progressive Supranuclear Palsy

Netherlands
Radboud University Medical Center
UCB Pharma; Verily Life Sciences LLC

Recruiting

The Personalized Parkinson Project de Novo Cohort (PPP-novo)

Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Parkinson Disease | Parkinsonian Disorders | Basal Ganglia Diseases | Movement Disorders | Neurodegenerative Diseases

Netherlands
Baseline Study LLC
Duke University; Stanford University; Verily Life Sciences LLC; Google LLC.

Active, not recruiting

Project Baseline Health Study

All

United States
Meril Life Sciences Pvt. Ltd.

Recruiting

Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis.

Aortic Valve Stenosis

Slovenia, Spain, Turkey, Italy, Netherlands, Estonia, Poland
Meril Life Sciences Pvt. Ltd.

Unknown

Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions. (Morph RCT-1)

Coronary Artery Disease
Meril Life Sciences Pvt. Ltd.

Unknown

Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System (MeRes-1Extend)

Coronary Artery Disease

Malaysia, Brazil, Indonesia, Macedonia, The Former Yugoslav Republic of
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
Meril Life Sciences Pvt. Ltd.

Recruiting

LANDMARK Trial: a Randomised Controlled Trial of Myval THV (LANDMARK)

Aortic Valve Stenosis

Sweden, Hungary, France, Belarus, Croatia, Germany, Netherlands, New Zealand, Poland, Portugal, Slovakia, Slovenia, Spain, Italy, Brazil, Estonia, Greece
Meril Life Sciences Pvt. Ltd.

Unknown

A Prospective, Single-arm, Multi-centre, Observational, Real World Registry (Morpheus)

Angina Pectoris

Jordan, Hungary, Malaysia, Netherlands
Meril Life Sciences Pvt. Ltd.

Completed

An Evaluation of BioMime™ - Sirolimus Eluting Coronary Stent in a Multi- Centre Study. (meriT-2)

Coronary Artery Disease

India
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Freedom® Total Knee System for Treatment of Osteoarthritis, Rheumatoid Arthritis or Post-traumatic Arthritis (Freedom®450)

Rheumatoid Arthritis | Knee Osteoarthritis | Post-traumatic Osteoarthritis
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease. (MeReS100-China)

Coronary Artery Disease
Meril Life Sciences Pvt. Ltd.

Unknown

BioMime Vs. Xience Randomised Control Clinical Study (meriT-V)

Coronary Artery Disease

United Kingdom, Brazil, Spain, Macedonia, The Former Yugoslav Republic of, Belgium, Czechia, Latvia, Netherlands, Poland
Dharma Life Sciences LLC

Completed

Reducing Anxiety Levels Through the Dharma Life App-Based and Mentor-Based Program Targeting Personality Characteristics: A Randomized Control Trial

Anxiety

United States
Banner Life Sciences LLC

Enrolling by invitation

Observational Study of Persistence on Bafiertam Treatment In Routine Clinical Practice (SIMPLE)

Relapsing Remitting Multiple Sclerosis

United States, Puerto Rico
Banner Life Sciences LLC

Completed

Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects

Relapsing Remitting Multiple Sclerosis
Banner Life Sciences LLC

Withdrawn

Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl Fumarate (PERSIST)

Relapsing Remitting Multiple Sclerosis
Banner Life Sciences LLC

Completed

Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers

Multiple Sclerosis

United States
Calico Life Sciences LLC

Available

Expanded Access to ABBV-CLS-484

Advanced Solid Tumor Cancer
Banner Life Sciences LLC

Completed

Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects

Relapsing Remitting Multiple Sclerosis

United States
Calico Life Sciences LLC
AbbVie

Completed

A Phase 1 Study Assessing the Effect of Food on the Pharmacokinetics of ABBV- CLS-7262

Healthy

United States
Calico Life Sciences LLC
AbbVie

Recruiting

A Phase 1 Study With ABBV-CLS-484 in Subjects With Locally Advanced or Metastatic Tumors

Advanced Solid Tumor Cancer

United States, Korea, Republic of, Spain, Israel, Japan, France
Calico Life Sciences LLC
AbbVie

Completed

A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects

Healthy

United States
Calico Life Sciences LLC
AbbVie

Recruiting

Study of [14C] ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration

Healthy Volunteer

United States
Calico Life Sciences LLC
AbbVie

Recruiting

A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects

Healthy

United States
Calico Life Sciences LLC
AbbVie

Recruiting

An Open-Label Exploratory Study of ABBV-CLS-7262 Subjects With Vanishing White Matter Disease

Vanishing White Matter Disease

United States, Netherlands
Calico Life Sciences LLC
AbbVie

Recruiting

First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

Advanced Solid Tumors Cancer

Korea, Republic of, Taiwan, Spain, United States, France, Japan, Israel
Calico Life Sciences LLC
AbbVie

Active, not recruiting

A Phase 1 Study to Investigate the Safety and Pharmacokinetics of ABBV-CLS-7262 in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis | ALS

United States, Canada
SerenaGroup, Inc.
Lacerta Life Sciences, LLC

Not yet recruiting

Clinical Trial Evaluating a Hyaluronic Acid Matrix in the Treatment of Chronic Non-healing Diabetic Foot Ulcers (DFUs)

Diabetic Foot
BioTeke USA, LLC
CSSi Life Sciences

Completed

Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test

COVID-19

United States
University National Heart Hospital
Meril Life Sciences Pvt. Ltd.

Recruiting

Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study) (SCA-DEB)

Coronary Artery Disease

Bulgaria
Pharmtechnology LLC
Reliance Life Sciences Private Limited

Completed

A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions

Healthy

India
SCRI Development Innovations, LLC
Achieve Life Sciences

Completed

Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer (Spruce)

Non Squamous Non Small Cell Lung Cancer

United States
Medical Group Care, LLC
CSSi Life Sciences

Completed

MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study

COVID-19 | Influenza A | Influenza B

United States
SCRI Development Innovations, LLC
Achieve Life Sciences

Completed

Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic Cancer (Rainier)

Pancreatic Cancer

United States
VGX Pharmaceuticals, LLC
GeneOne Life Science, Inc.

Completed

Phase I Safety and Pharmacokinetic Study of VGX-1027 in Healthy Subjects

Healthy

United States
VGX Pharmaceuticals, LLC
GeneOne Life Science, Inc.

Completed

Multiple-Dose Study of VGX-1027 in Healthy Subjects

Healthy

United States

Clinical Trials Sponsored by Verily Life Sciences LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations